共 78 条
[1]
Smith BD(2012)Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965 MMWR Recomm Rep 61 1-36
[2]
Morgan RL(2010)Aging of hepatitis C virus (HCV)-infected persons in the United States: A multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 513-521
[3]
Beckett GA(1999)Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. The interventional therapy group Hepatology 30 550-555
[4]
Davis GL(2007)The effects of HCV infection and management on health-related quality of life Hepatology 45 806-816
[5]
Alter MJ(2012)Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection Journal of Gastroenterology and Hepatology 27 149-157
[6]
El-Serag H(2010)Humanistic and economic impacts of hepatitis C infection in the United States Journal of Medical Economics 13 709-718
[7]
Poynard T(2009)Diagnosis, management, and treatment of hepatitis C: An update Hepatology 49 1335-1374
[8]
Jennings LW(2005)Estimation of utilities for chronic hepatitis C from SF-36 scores American Journal of Gastroenterology 100 643-651
[9]
Ware JE(2007)Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders Liver International 27 1217-1225
[10]
Bayliss MS(2004)The impact of peginterferon alfa-2a plus RBV combination therapy on health-related quality of life in chronic hepatitis C Journal of Hepatology 40 675-681